Zydus Cadila says 'positive results' from phase 2 studies of COVID-19 drug Desidustat in Mexico

In June 2020, Zydus Cadila had received approval from Mexico's regulatory authority Cofepris to test one of its lead research candidate Desidustat in the management of COVID-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ocB1bP
via IFTTT